pharmaphorum January 29, 2024
Finland’s Orion Corp has entered into a licensing agreement with digital therapeutics (DTx) specialist Newel Health, handing over rights to an app designed to support patients with chronic pain.
Newel gains exclusive worldwide rights to develop, manufacture, and commercialise the app, called Rohkea or ODD-403, which uses virtual reality to deliver a gamified treatment programme for chronic pain that specifically aims to address patients’ fear of movement and re-injury.
Rohkea – a Finnish word meaning brave or bold – encourages patients with chronic pain to navigate a virtual, open-world landscape using their whole bodies, carrying out tasks such as writing or drawing on an easel, picking fruit, packing fitting items into a box, and solving puzzles using physical movements.
The...
Today's Sponsors
Today's Sponsor